These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The medical treatment of epilepsy: initiation of drug therapy. Livingston S, Pruce I, Pauli LL. Pediatr Ann; 1979 Apr; 8(4):213-31. PubMed ID: 223107 [No Abstract] [Full Text] [Related]
3. Effect of treatment and additional disease on pharmacokinetic of valproic acid in children with epilepsy. Juárez-Olguín H, Lugo-Goytia G, Flores-Murrieta F, Ruiz-García M, Lares Asseff I, Flores Pérez J. Rev Invest Clin; 2010 Apr; 62(6):516-23. PubMed ID: 21416779 [Abstract] [Full Text] [Related]
10. [Lafora's disease: one of the causes for drug-resistant epilepsy in adolescence]. Verrotti A, Trotta D, Di Corcia G, Blasetti A, Cutarella R, Basciani F, Chiarelli F. Minerva Pediatr; 2001 Oct 28; 53(5):515-6. PubMed ID: 11668299 [No Abstract] [Full Text] [Related]
13. [Treatment of newly diagnosed epileptic crises. A French experience]. Groupe CAROLE (Coordination Active du Réseau Observatoire Longitudinal de l'Epilepsie). Rev Neurol (Paris); 2001 Dec 28; 157(12):1500-12. PubMed ID: 11924446 [Abstract] [Full Text] [Related]
15. Comparative study on the dynamics of the electroencephalographical changes in the petit mal epilepsy during both classical and valproic acid treatment. Tudosie M, Popoviciu L, Roman V. Neurol Psychiatr (Bucur); 1987 Dec 28; 25(2):117-27. PubMed ID: 3110933 [No Abstract] [Full Text] [Related]
16. First-drug treatment failures in children newly diagnosed with epilepsy. Dudley RW, Penney SJ, Buckley DJ. Pediatr Neurol; 2009 Feb 28; 40(2):71-7. PubMed ID: 19135617 [Abstract] [Full Text] [Related]